Company Valuation: Edwards Lifesciences Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 56,859 80,883 46,128 46,246 43,663 48,223 48,223 -
Change - 42.25% -42.97% 0.25% -5.58% 10.44% 0% -
Enterprise Value (EV) 1 56,271 80,616 45,956 45,198 40,285 44,752 43,484 41,865
Change - 43.26% -42.99% -1.65% -10.87% 11.09% -2.84% -3.72%
P/E ratio 70.2x 54.4x 30.6x 33.2x 10.6x 36.6x 30.6x 27.3x
PBR 12.7x 13.9x 7.82x 6.99x 4.36x 4.51x 4.15x 3.84x
PEG - 0.7x 12.14x -5.79x 0x -0.5x 1.6x 2.3x
Capitalization / Revenue 13x 15.5x 8.57x 7.7x 8.03x 7.99x 7.29x 6.64x
EV / Revenue 12.8x 15.4x 8.54x 7.53x 7.41x 7.42x 6.57x 5.76x
EV / EBITDA 39.4x 46.6x 23.7x 24.1x 24.1x 24.6x 21.3x 18.3x
EV / EBIT 42.6x 50.6x 25.6x 26.1x 26.6x 27x 23.2x 19.9x
EV / FCF 86.9x 57.3x 47.2x 47.9x 139x 35.2x 28.7x 23.4x
FCF Yield 1.15% 1.74% 2.12% 2.09% 0.72% 2.84% 3.48% 4.27%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 1.3 2.38 2.44 2.3 6.97 2.268 2.712 3.041
Distribution rate - - - - - - - -
Net sales 1 4,386 5,232 5,382 6,005 5,440 6,032 6,617 7,263
EBITDA 1 1,429 1,729 1,936 1,879 1,670 1,822 2,043 2,290
EBIT 1 1,322 1,594 1,796 1,734 1,514 1,660 1,873 2,100
Net income 1 823.4 1,503 1,522 1,402 4,175 1,317 1,583 1,775
Net Debt 1 -588.2 -267 -172.7 -1,048 -3,378 -3,471 -4,739 -6,358
Reference price 2 91.23 129.55 74.61 76.25 74.03 83.10 83.10 83.10
Nbr of stocks (in thousands) 623,248 624,334 618,260 606,500 589,800 580,300 580,300 -
Announcement Date 27/1/21 26/1/22 31/1/23 6/2/24 11/2/25 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
36.64x7.42x24.56x-.--% 48.22B
34.85x5.92x23.41x0.27% 234B
73.1x19x44.33x-.--% 194B
45.08x7.4x24x0.52% 168B
45.59x7.36x24.01x-.--% 139B
22.43x2.63x12.84x2.17% 61.18B
27.53x5.77x20.1x0.71% 41.37B
18.61x2.14x12.02x0.15% 38.86B
24.7x6.53x16.89x0.93% 37.8B
26.36x6.75x19.28x2.52% 36.03B
Average 35.49x 7.09x 22.14x 0.73% 99.8B
Weighted average by Cap. 43.20x 8.68x 26.09x 0.45%
See all sector valuations

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. EW Stock
  4. Valuation Edwards Lifesciences Corporation